Michael Chen

Managing Director & Investment Committee Member

David Li

Founder, Chief Executive Officer & Chairman

47 past transactions

Loho Eyewear

Series C in 2018
Loho Eyewear Lifestyle offers an all-in-one service including eyewear design, production, sales, and customer support. LOHO Eyewear operates an online to offline eyewear retail platform.

Keking

Series C in 2018
Shanghai Keking Xinda Technology Group Co., Ltd. operates a SaaS platform that provides transportation coordination and payment solutions for the logistics industry. It offers services, such as waybill management, fast payment, financial optimization, vehicle management, capital turnover, and etc. The company was founded in 2015 and is based in Shanghai, China.

Zhangtongjiayuan

Series D in 2018
Xiamen Shenzhou Eagle Software Technology Co., Ltd. is a high-tech enterprise specializing in R & D management platform, which was established on January 25, 2011 with a registered capital of 22.442 million.

Shenhen Lehuo E-commerce Co., Ltd.

Private Placement in 2018
Shenhen Lehuo E-commerce Co., Ltd. operates an online to offline eyewear retail platform. The company was founded in 2012 and is based in Shenzhen, China.

Sinotau

Series D in 2021
Beijing Sinotau Intl. Pharmaceutical Technology Co., Ltd. operates as an integrated pharmaceutical group that offers generic and patented therapies and diagnostic agents. The company provides radiopharmaceutical and bio-pharmaceuticals products. It manufactures antibiotics, vitamins, hormone, oncology, digestive system, cardiovascular system, diabetes, respiratory system, and gynecology tablets, capsules, and granules. The company was founded in 2005 and is based in Beijing, China with an additional office in Haikou, China.

Reading Technology

Series A in 2021
Reading Technology is an R&D company that uses imaging, data, AI diagnosis, and treatment technology for heart and brain diseases.

Fadada

Series D in 2021
Fadada.com is an online platform offering services of online electronic contracts signature, electronic documents signature, evidence custody and other related electronic signature SaaS services. The company is third-party electronic contract platform in China, mainly for finance, real estate, automotive, human resources services, education, insurance, third-party payment, tourism, medical, logistics, supply chain, B2B, B2C online trading platform and other industries and government agencies provide electronic contracts, electronic document signing and depositing services, while integrating value-added services such as forensic and lawyer services.

Iluvatar CoreX

Series B in 2019
Iluvatar Corex Inc develops cloud computing chips and computing infrastructure software. The company also offers chip products, such as, big island; a server level computing chip, treasure island; a computing chip for edge side reasoning, and Iluvator Internet protocol core; a fully independent intellectual property Internet protocol core developer. The company also offers appliances, such as, SkyACE and SkyAXE. The company was founded in 2015 and is based in Nanjing, China with additional offices in Shanghai, Beijing, Ningbo; China, and San Jose, California.
Beijing Jingdu Children's Hospital is headquartered in Beijing, China.

Taibang Biological Group

Private Placement in 2018
China Biologic Products Holdings, Inc. (NASDAQ: CBPO), is a leading fully integrated plasma-based biopharmaceutical company in China. Their core capabilities include plasma collection, research and development, manufacturing, and commercialization of human plasma-based biopharmaceutical products. Their company was founded in 2002 and was listed on NASDAQ in 2009. Their products are used as critical therapies during medical emergencies and for the prevention and treatment of life-threatening diseases and immune-deficiency related diseases. Backed by robust research and development capabilities, they aim to capture substantially all of the value along the plasma products value chain, and to develop their technology to enhance life quality and create value for more patients. They have expanded their product portfolio to eight categories of plasma-based products, including human albumin, immunoglobulin for intravenous injection and coagulation factor products, as well as other biopharmaceutical products, and they continue to make progress on new pipeline products.

Yunxuetang

Series D in 2020
Jiangsu cloud school network Technology Co., Ltd. was established in December 2011. As a comprehensive training platform for enterprise training, cloud school will be the leading Internet technology and personnel training concept applied to the enterprise personnel training and development, and effectively help corporate customers to enhance the value of talent, help enterprises succeed. The BaaS model, which is the development of the enterprise's talent development business, provides the professional enterprise university's overall solution through the "software platform, course service, course creation tool, operation service" and other dimensions. Cloud school music advocate "a business is a university" concept, is the cloud school BaaS business model landing on behalf of the product.

Shanghai ANE Logistics

Private Equity Round in 2020
Shanghai ANE Logistics is a less than truckload(LTL) operator with a franchise model in China. ANE pioneers the franchise model in China’s LTL industry and has established a robust national delivery network through self-operated sorting centers, contracted line-haul trucks and franchised pick-up-and-delivery stores.The company currently has about 5,000 franchised stores nationwide.

Luckin Coffee

Series B in 2019
Luckin coffee, a representative of China's new retail coffee, is committed to becoming a leading high-quality coffee brand and professional coffee service provider in the country. Luckin coffee, with preferred raw materials, exquisite coffee technology, innovative business models and leading mobile internet technologies, is striving to bring a higher quality coffee consumer experience to consumers and promote the popularization and development of coffee culture in China.

UIB

Private Equity Round in 2018
UIB is a leading Chinese obstetrics, gynecology and pediatrics hospital chain headquartered in Shanghai. UIB currently owns the UIB International Postpartum Care Center and the Ruizhitang Women’s Healthcare Center, and plans to launch the Shanghai Everbetter Maternity Hospital and the Shanghai Everbetter Pubin Children’s Hospital in 2016.

Haiziwang

Private Equity Round in 2019
Haiziwang is an emerging maternity-infant-children specialty retailer as well as a child growth and development service provider.

Goumee

Series B in 2021
Jiaxing Goumee Information Technology Co., Ltd. is a traffic service provider that focuses on women's fashion. It focuses on fashion tide and beauty skin care products. The company was founded in 2016 and is based in Jiaxing, China.

Innogen Pharmaceutical

Private Equity Round in 2024
Innogen Pharmaceutical Technology is a high-tech, innovation-driven international pharmaceutical manufacturing, and R&D company.

Yogo Robot

Series C in 2022
Shanghai Yogo Robot Co., Ltd. develops robots. The firm was founded in 2016 and is headquartered in Shanghai, China.

MitrAssist

Venture Round in 2020
MitrAssist introduces a minimally invasive approach to MR treatment. Its mitral valve implant works in unison with the natural mitral valve without harming its functionality. MitrAssist has developed a new approach to treating MR that is neither repair nor replacement. Instead, its proprietary valve implant is placed on top of the natural valve to work in unison with it and to enhance valve functionality. MitrAssist’s “valve-in-valve” approach overcomes the various challenges of MR and offers an improved treatment solution for all MR patients. It has significant advantages over minimally invasive solutions – both existing and in development.

Meican

Series E in 2021
Meican.com (美餐) is a platform and website focused on providing mobile ordering of foods, detailed take-out menus as well as personal and enterprise meal ordering services. It enables users choose meals by themselves from many cooperative restaurants and enjoy personalized delicacy. Meican.com also enables enterprises become efficient in terms of delivering orders as well as solving the problems of food classification and settlement so that they can focus on their core business. Meican.com has vast experience of product research and development and offline operation due to its professional team. Established in Jan. 2011, Meican.com covers four major cities like Beijing, Shanghai, Guangzhou and Shenzhen, and it owns more than 30,000 cooperative restaurants.
Xiamen Shenzhou Software Technology Co., Ltd. develops Zhang Tong Jia Yuan, a mobile application to connect parents and pre-school teachers. The company is a technology enterprise that develops mobile Internet education platform and audio and video compression technology. The company was founded in 2011 and is based in Xiamen, China.

Beijing Laso Biotechnology Co., Ltd.

Private Placement in 2020
Beijing Laso Biotechnology Co., Ltd. is a health-tech company specializing in predictive genetic analysis. It was founded in 2018 and is based in Beijing, China.

Luckin Coffee

Series A in 2018
Luckin coffee, a representative of China's new retail coffee, is committed to becoming a leading high-quality coffee brand and professional coffee service provider in the country. Luckin coffee, with preferred raw materials, exquisite coffee technology, innovative business models and leading mobile internet technologies, is striving to bring a higher quality coffee consumer experience to consumers and promote the popularization and development of coffee culture in China.

Luckin Coffee

Post in 2021
Luckin coffee, a representative of China's new retail coffee, is committed to becoming a leading high-quality coffee brand and professional coffee service provider in the country. Luckin coffee, with preferred raw materials, exquisite coffee technology, innovative business models and leading mobile internet technologies, is striving to bring a higher quality coffee consumer experience to consumers and promote the popularization and development of coffee culture in China.

Iluvatar CoreX

Series C in 2021
Iluvatar Corex Inc develops cloud computing chips and computing infrastructure software. The company also offers chip products, such as, big island; a server level computing chip, treasure island; a computing chip for edge side reasoning, and Iluvator Internet protocol core; a fully independent intellectual property Internet protocol core developer. The company also offers appliances, such as, SkyACE and SkyAXE. The company was founded in 2015 and is based in Nanjing, China with additional offices in Shanghai, Beijing, Ningbo; China, and San Jose, California.

1KMXC

Series C in 2019
1KMXC is a high-tech research and development company for artificial intelligence robot solutions. The company provides robotic car wash service that covers many provinces and cities across China. It has obtained Alibaba investment with a financing amount of over 100 million.

AutocloudPro

Series C in 2019
The "CarTongyun" intelligent maintenance platform provides accurate information through its comprehensive database. The system covers nearly 2,500 vehicles, including imported, autonomous, joint venture vehicles, and nearly 150,000 vehicle types. At present, more than 80% of the models required by the domestic auto repair industry, in which the part data of each model has covered all the parts damaged by daily collisions, covering more than 95% of the total. Quickly locate and repair the required parts information, and at the same time, it can provide data support for user procurement, loss determination, and out-of-factory rescue scenarios according to the related parameters such as coding query and original price.

Shanghai ANE Logistics

Private Placement in 2020
Shanghai ANE Logistics is a less than truckload(LTL) operator with a franchise model in China. ANE pioneers the franchise model in China’s LTL industry and has established a robust national delivery network through self-operated sorting centers, contracted line-haul trucks and franchised pick-up-and-delivery stores.The company currently has about 5,000 franchised stores nationwide.
China Biologic Products Holdings, Inc. (NASDAQ: CBPO), is a leading fully integrated plasma-based biopharmaceutical company in China. Their core capabilities include plasma collection, research and development, manufacturing, and commercialization of human plasma-based biopharmaceutical products. Their company was founded in 2002 and was listed on NASDAQ in 2009. Their products are used as critical therapies during medical emergencies and for the prevention and treatment of life-threatening diseases and immune-deficiency related diseases. Backed by robust research and development capabilities, they aim to capture substantially all of the value along the plasma products value chain, and to develop their technology to enhance life quality and create value for more patients. They have expanded their product portfolio to eight categories of plasma-based products, including human albumin, immunoglobulin for intravenous injection and coagulation factor products, as well as other biopharmaceutical products, and they continue to make progress on new pipeline products.

Beijing Laso Biotechnology Co., Ltd.

Private Placement in 2019
Beijing Laso Biotechnology Co., Ltd. is a health-tech company specializing in predictive genetic analysis. It was founded in 2018 and is based in Beijing, China.
Ding Ao (Shanghai) Network Technology Co., Ltd. operates an intelligent maintenance platform that provides cloud platform services for auto parts big data for insurance, accessory, and repair industries. It also sells accessories online. The company was founded on 2014 and is based in Beijing, China.

Keking

Private Placement in 2018
Shanghai Keking Xinda Technology Group Co., Ltd. operates a SaaS platform that provides transportation coordination and payment solutions for the logistics industry. It offers services, such as waybill management, fast payment, financial optimization, vehicle management, capital turnover, and etc. The company was founded in 2015 and is based in Shanghai, China.

Taibang Biological Group

Investor Activism in 2019
China Biologic Products Holdings, Inc. (NASDAQ: CBPO), is a leading fully integrated plasma-based biopharmaceutical company in China. Their core capabilities include plasma collection, research and development, manufacturing, and commercialization of human plasma-based biopharmaceutical products. Their company was founded in 2002 and was listed on NASDAQ in 2009. Their products are used as critical therapies during medical emergencies and for the prevention and treatment of life-threatening diseases and immune-deficiency related diseases. Backed by robust research and development capabilities, they aim to capture substantially all of the value along the plasma products value chain, and to develop their technology to enhance life quality and create value for more patients. They have expanded their product portfolio to eight categories of plasma-based products, including human albumin, immunoglobulin for intravenous injection and coagulation factor products, as well as other biopharmaceutical products, and they continue to make progress on new pipeline products.
Jiangsu Yunxuetang Network Technology Co., Ltd. provides training services, exams, and learning materials for real estate, banking, insurance, and retail sectors. The company was founded in 2011 and is based in Suzhou, China.

MitrAssist Medical Ltd.

Private Placement in 2020
MitrAssist Medical Ltd. develops and manufactures cardiology medical devices for patient suffering from mitral regurgitation (MR). The company develops mitral valve implant that is placed on top of the heart’s own mitral valve and works in unison with it to enhance the valve’s functionality. MitrAssist Medical Ltd. was founded in 2009 and is based in Misgav, Israel.

Iluvatar CoreX

Private Placement in 2019
Iluvatar Corex Inc develops cloud computing chips and computing infrastructure software. The company also offers chip products, such as, big island; a server level computing chip, treasure island; a computing chip for edge side reasoning, and Iluvator Internet protocol core; a fully independent intellectual property Internet protocol core developer. The company also offers appliances, such as, SkyACE and SkyAXE. The company was founded in 2015 and is based in Nanjing, China with additional offices in Shanghai, Beijing, Ningbo; China, and San Jose, California.

Beijing Jingdu Children's Hospital

Merger/Acquisition in 2020
Beijing Jingdu Children's Hospital is headquartered in Beijing, China.

Luckin Coffee

Private Placement in 2018
Luckin coffee, a representative of China's new retail coffee, is committed to becoming a leading high-quality coffee brand and professional coffee service provider in the country. Luckin coffee, with preferred raw materials, exquisite coffee technology, innovative business models and leading mobile internet technologies, is striving to bring a higher quality coffee consumer experience to consumers and promote the popularization and development of coffee culture in China.

PhiSkin

Private Equity Round in 2020
PhiSkin operates as a skin and laser clinic. The company is based in China.

MitrAssist

Series C in 2023
MitrAssist introduces a minimally invasive approach to MR treatment. Its mitral valve implant works in unison with the natural mitral valve without harming its functionality. MitrAssist has developed a new approach to treating MR that is neither repair nor replacement. Instead, its proprietary valve implant is placed on top of the natural valve to work in unison with it and to enhance valve functionality. MitrAssist’s “valve-in-valve” approach overcomes the various challenges of MR and offers an improved treatment solution for all MR patients. It has significant advantages over minimally invasive solutions – both existing and in development.

NTX™

Series C in 2022
NTX™ is committed to creating revolutionary textile solutions through continuous research and innovation that are ecologically and economically sustainable.

Taibang Biological Group

Merger/Acquisition in 2019
China Biologic Products Holdings, Inc. (NASDAQ: CBPO), is a leading fully integrated plasma-based biopharmaceutical company in China. Their core capabilities include plasma collection, research and development, manufacturing, and commercialization of human plasma-based biopharmaceutical products. Their company was founded in 2002 and was listed on NASDAQ in 2009. Their products are used as critical therapies during medical emergencies and for the prevention and treatment of life-threatening diseases and immune-deficiency related diseases. Backed by robust research and development capabilities, they aim to capture substantially all of the value along the plasma products value chain, and to develop their technology to enhance life quality and create value for more patients. They have expanded their product portfolio to eight categories of plasma-based products, including human albumin, immunoglobulin for intravenous injection and coagulation factor products, as well as other biopharmaceutical products, and they continue to make progress on new pipeline products.

Genebox

Series A in 2019
Genebox is a leading consumer genetics company.